CompletedEUCTR 2005-005345-19

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Flexibly-Dosed Extended-Release Paliperidone as Adjunctive Therapy to Mood S...

This historical record does not confirm current site availability.

Historical research recordBelgium + EstoniaBipolarity

The study in practice

Understand this study

What did researchers investigate?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Listed locations: Belgium · Estonia
Study phase: Phase 3

Get this study by email

Study clarity

Study information

Study start dateNot clearly listed

Recruitment status: Completed
Enrollment listed in the registry: 296
Sponsor: Janssen-Cilag International N.V.
Sponsor type: Unknown or unclear
Study type: Drug
Intervention type: Drug
Study phase: Phase 3
Locations: Belgium, Estonia
Age range: Not clearly listed
Official registry ID: EUCTR 2005-005345-19
Official title: Show the full official title
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Flexibly-Dosed Extended-Release Paliperidone as Adjunctive Therapy to Mood S...

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Belgium · Estonia

Registry details

Historical country statuses

Belgium — Completed
Estonia — Completed

Interested in joining this study?

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Janssen-Cilag International N.V.

Want to explore more studies?

Explore studies